Biomet Pays to Defer Bribery Prosecution (Walter Eisner @ OTW)
The U.S. Department of Justice's Criminal Division (DOJ) announced on March 26, that Biomet Inc. has entered into a deferred prosecution agreement (DPA) with the government to, "resolve improper payments by the company and its subsidiaries in violation of the Foreign Corrupt Practices Act (FCPA).
Biomet agreed to pay over $22 million to avoid prosecution and resolve charges brought by the DOJ under the FCPA.
Bribery Investigation
According to the announcement, the matter is part of an investigation into bribery by medical device co...
The Orthopedics Industry 
